These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2597997)

  • 1. Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy.
    van der Meché FG; Vermeulen M; Busch HF
    Brain; 1989 Dec; 112 ( Pt 6)():1563-71. PubMed ID: 2597997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late motor involvement in cases presenting as "chronic sensory demyelinating polyneuropathy".
    Berger AR; Herskovitz S; Kaplan J
    Muscle Nerve; 1995 Apr; 18(4):440-4. PubMed ID: 7715630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and electrophysiological correlation in chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin therapy: a case report.
    Han NH; Huang CC; Tsai CP
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jan; 59(1):42-6. PubMed ID: 9134822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory pathophysiology in chronic acquired demyelinating neuropathy.
    Krarup C; Trojaborg W
    Brain; 1996 Feb; 119 ( Pt 1)():257-70. PubMed ID: 8624687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy.
    Clouston PD; Kiers L; Zuniga G; Cros D
    Electroencephalogr Clin Neurophysiol; 1994 Aug; 93(4):245-54. PubMed ID: 7521284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement.
    van Doorn PA; Vermeulen M; Brand A; Mulder PG; Busch HF
    Arch Neurol; 1991 Feb; 48(2):217-20. PubMed ID: 1847041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
    Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between axonal and demyelinating neuropathies: identical segments recorded from proximal and distal muscles.
    Raynor EM; Ross MH; Shefner JM; Preston DC
    Muscle Nerve; 1995 Apr; 18(4):402-8. PubMed ID: 7715625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Otto M; Markvardsen L; Tankisi H; Jakobsen J; Fuglsang-Frederiksen A
    Acta Neurol Scand; 2017 Jun; 135(6):656-662. PubMed ID: 27546708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy.
    Cappelen-Smith C; Kuwabara S; Lin CS; Mogyoros I; Burke D
    Ann Neurol; 2000 Dec; 48(6):826-32. PubMed ID: 11117538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy.
    Faed JM; Day B; Pollock M; Taylor PK; Nukada H; Hammond-Tooke GD
    Neurology; 1989 Mar; 39(3):422-5. PubMed ID: 2927654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nerve conduction abnormalities in chronic inflammatory demyelinating polyneuropathy (CIDP)].
    Baba M
    Rinsho Shinkeigaku; 1991 Dec; 31(12):1333-6. PubMed ID: 1817802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
    Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
    Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy.
    Kaji R; Shibasaki H; Kimura J
    Neurology; 1992 Mar; 42(3 Pt 1):506-9. PubMed ID: 1549209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distal sensory fiber involvement in inflammatory demyelinating polyneuropathies.
    Fraser JL
    Muscle Nerve; 1994 Jan; 17(1):112-3. PubMed ID: 8264690
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteration of proximal conduction velocity at distal nerve injury in carpal tunnel syndrome: demyelinating versus axonal change.
    Chang MH; Liu LH; Lee YC; Hsieh PF
    J Clin Neurophysiol; 2008 Jun; 25(3):161-6. PubMed ID: 18469728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinicophysiologic study of central and peripheral motor conduction in hereditary demyelinating motor and sensory neuropathy.
    Mano Y; Nakamuro T; Ikoma K; Takayanagi T; Mayer RF
    Electromyogr Clin Neurophysiol; 1993 Mar; 33(2):101-7. PubMed ID: 8449165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conduction slowing in diabetic distal polyneuropathy.
    Herrmann DN; Ferguson ML; Logigian EL
    Muscle Nerve; 2002 Aug; 26(2):232-7. PubMed ID: 12210388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy.
    Tankisi H; Otto M; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2012 Oct; 123(10):2099-105. PubMed ID: 22560637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid improvement of nerve conduction in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Saito Y; Yokota T
    Rinsho Shinkeigaku; 1993 Oct; 33(10):1066-9. PubMed ID: 8293607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.